Ye, X., Ye, X., Wang, L., Liu, W., Liu, W., Wang, M., . . . Du, Q. (2025). Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: A retrospective real-world analysis. Frontiers Media S.A.
Chicago Style (17th ed.) CitationYe, Xuan, et al. Efficacy and Safety of Biosimilar Trastuzumab (HLX02) in Patients with HER2-positive Advanced Breast Cancer: A Retrospective Real-world Analysis. Frontiers Media S.A, 2025.
MLA (9th ed.) CitationYe, Xuan, et al. Efficacy and Safety of Biosimilar Trastuzumab (HLX02) in Patients with HER2-positive Advanced Breast Cancer: A Retrospective Real-world Analysis. Frontiers Media S.A, 2025.
Warning: These citations may not always be 100% accurate.